Literature DB >> 7943291

Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle.

S R Price1, B K England, J L Bailey, K Van Vreede, W E Mitch.   

Abstract

In rat muscle metabolic acidosis increases ATP-dependent protein degradation and levels of mRNAs for ubiquitin (Ub) and proteasome subunits. Because adrenalectomy (ADX) abolishes the proteolytic response to acidosis in muscle, we examined whether glucocorticoids (GCs) are necessary for acidosis-induced changes in Ub and proteasome mRNAs in muscles. Total RNA content of the white fiber extensor digitorum longus or mixed fiber gastrocnemius muscles were lowest in muscles of ADX rats given acid plus GCs. In contrast, the abundance of Ub and C2 and C9 proteasome subunits mRNAs were increased in muscles from this group compared with untreated ADX rats or ADX rats given acid or GCs alone. Because total RNA is reduced, the increase in these mRNAs in muscles of ADX rats receiving acid plus GCs provides evidence for a specific activation of the ATP-dependent-Ub-proteasome pathway. Thus, GCs are required but not sufficient to produce the coordinated increase in mRNAs encoding ubiquitin and proteasome subunits occurring in muscles of acidotic rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943291     DOI: 10.1152/ajpcell.1994.267.4.C955

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  38 in total

Review 1.  Mechanisms accelerating muscle atrophy in catabolic diseases.

Authors:  W E Mitch
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Effect of age on skeletal muscle proteolysis in extensor digitorum longus muscles of B6C3F1 mice.

Authors:  Thomas H Reynolds; Katherine M Krajewski; Lisa M Larkin; Pamela Reid; Jeffrey B Halter; Mark A Supiano; Donald R Dengel
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-05       Impact factor: 6.053

3.  Malnutrition: a frequent misdiagnosis for hemodialysis patients.

Authors:  William E Mitch
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

4.  Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles.

Authors:  Lydie Combaret; Daniel Taillandier; Dominique Dardevet; Daniel Béchet; Cécile Rallière; Agnès Claustre; Jean Grizard; Didier Attaix
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

Review 5.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

6.  Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription.

Authors:  S R Price; J L Bailey; X Wang; C Jurkovitz; B K England; X Ding; L S Phillips; W E Mitch
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 7.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

8.  Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.

Authors:  G Garibotto; A Barreca; R Russo; A Sofia; P Araghi; A Cesarone; M Malaspina; F Fiorini; F Minuto; A Tizianello
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

9.  Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging.

Authors:  D Dardevet; C Sornet; D Taillandier; I Savary; D Attaix; J Grizard
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 10.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.